Remote Ischemic Conditioning in STEMI to Decrease Infarct Size
- Conditions
- CADSTEMI
- Registration Number
- NCT03930589
- Lead Sponsor
- University of Alberta
- Brief Summary
Following acute STEMI patients may have significant myocardial damage and subsequent heart failure. There is currently conflicting data regarding the benefit of remote ischemic conditioning to decrease the magnitude of infarction. Remote ischemic condition is a process where by repetitive intermittent limb ischemia is used to decrease the magnitude of myocardial damage caused by coronary artery occlusion and the subsequent reperfusion injury in STEMI patients. RemCon-STEMI is a multicenter randomized trial to test the impact of remote ischemic conditioning in acute STEMI.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 251
Patients presenting with STEMI within 6 hours of symptom onset and:
- Are expected to receive reperfusion therapy with either fibrinolysis or primary PCI.
- Documented informed consent (verbal)
- Cardiogenic shock
- History of anatomical deformity or vascular complication that limit ability to conduct remote ischemic preconditioning
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Composite of all cause death 90 days all cause death, cardiogenic shock or chf through 90 days
- Secondary Outcome Measures
Name Time Method long term survival up to 1 year survival
myocardial infarction size within 72 hours of hospital admission mi size using peak elevation of cardiac biomarkers
ECG infarct size with 10 days or hospital discharge whichever occurs first QRS score on baseline and discharge ECGS
Reperfusion within 24 hours of admission to hospital ST segment resolution 30 minutes post PCI
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.